Metrics
7 Record Views
- Title
- Abstract CT215: Fibroblast growth factor receptor (FGFR) inhibition demonstrates anti-tumor activity in succinate dehydrogenase deficient gastrointestinal stromal tumor (SDHd GIST)
- Creators
- Priscilla Merriam - Dana-Farber Cancer InstituteJames J. Morrow - Dana-Farber Cancer InstituteEmanuele Mazzola - Dana-Farber Cancer InstituteNicole L. Solimini - Harvard UniversityPrafulla C. Gokhale - Dana-Farber Cancer InstitutePing Chi - Memorial Sloan Kettering Cancer CenterAlice Chen - National Cancer InstituteMark Agulnik - City Of Hope National Medical CenterMelissa Burgess - UPMC Hillman Cancer CenterScott Schuetze - University of Michigan–Ann ArborNeeta Somaiah - The University of Texas MD Anderson Cancer CenterBrian A. Van Tine - Washington University in St. LouisSeth Pollack - Northwestern Memorial HospitalGabriel Tinoco - The Ohio State UniversityJonathan Trent - University of MiamiBreelyn Wilky - University of Colorado DenverNicola Bothwick - Dana-Farber Cancer InstituteShahanawaz Jiwani - Frederick National Laboratory for Cancer ResearchPeter Wu - Frederick National Laboratory for Cancer ResearchLorraine Pelosof - National Cancer InstituteMatthew Hemming - University of Massachusetts Chan Medical SchoolGeoffrey Shapiro - Dana-Farber Cancer InstituteGeorge Demetri - Dana-Farber Cancer InstituteBradley Bernstein - Harvard UniversitySuzanne George - Dana-Farber Cancer Institute
- Publication Details
- Cancer research (Chicago, Ill.), Vol.85(8_Supplement_2), pp.CT215-CT215
- Academic Unit
- Miller School of Medicine; UMMG Dept of Medicine - Hematology/Oncology
- Language
- English
- Resource Type
- Journal article
- Record Identifier
- 991032664908202976